Wild-type p53 mediates positive regulation of gene expression through a specific DNA sequence element.
暂无分享,去创建一个
A. Levine | J. Bargonetti | C. Prives | G. Zambetti | K. Walker | G P Zambetti | A J Levine | C Prives | J Bargonetti | K Walker | Kristen K. Walker | Carol Prives | Arnold J. Levine | Gerard P. Zambet | Jill Bargonett
[1] B. Howard,et al. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells , 1982, Molecular and cellular biology.
[2] J. Johnson,et al. The muscle creatine kinase gene is regulated by multiple upstream elements, including a muscle-specific enhancer , 1988, Molecular and cellular biology.
[3] B. Vogelstein,et al. Wild-type but not mutant p53 immunopurified proteins bind to sequences adjacent to the SV40 origin of replication , 1991, Cell.
[4] T. Soussi,et al. Cloning and characterization of a cDNA from Xenopus laevis coding for a protein homologous to human and murine p53. , 1987, Oncogene.
[5] D. Ledbetter,et al. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. , 1989, Science.
[6] P. Friedman,et al. Wild-type p53 activates transcription in vitro , 1992, Nature.
[7] M. Yaniv,et al. Wild-type p53 can down-modulate the activity of various promoters. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[8] G. Lozano,et al. Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene. , 1990, Science.
[9] G. Lozano,et al. Analysis of p53 mutants for transcriptional activity , 1991, Molecular and cellular biology.
[10] O. Halevy,et al. Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53 , 1990, Cell.
[11] J. Minna,et al. p53: a frequent target for genetic abnormalities in lung cancer. , 1989, Science.
[12] H. Koeffler,et al. Rearrangement of the p53 gene in human osteogenic sarcomas. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[13] A. Levine,et al. p53 alteration is a common event in the spontaneous immortalization of primary BALB/c murine embryo fibroblasts. , 1991, Genes & development.
[14] K. Kinzler,et al. Identification of p53 as a sequence-specific DNA-binding protein , 1991, Science.
[15] V. Rotter,et al. Mutant p53 proteins bind DNA abnormally in vitro. , 1991, Oncogene.
[16] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[17] D. Goeddel,et al. The amino acid sequence of murine p53 determined from a c-DNA clone. , 1984, Virology.
[18] P. Friedman,et al. The murine p53 protein blocks replication of SV40 DNA in vitro by inhibiting the initiation functions of SV40 large T antigen , 1989, Cell.
[19] E. Appella,et al. Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[20] W. Deppert,et al. DNA binding properties of murine p53. , 1988, Oncogene.
[21] F. Collins,et al. Mutations in the p53 gene occur in diverse human tumour types , 1989, Nature.
[22] S. Tapscott,et al. The MCK enhancer contains a p53 responsive element. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[23] S. Fields,et al. Presence of a potent transcription activating sequence in the p53 protein. , 1990, Science.
[24] B. Vogelstein,et al. p53 mutations in human cancers. , 1991, Science.
[25] A. Levine,et al. Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life , 1988, Molecular and cellular biology.
[26] A. Levine,et al. Characterization of a 54K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells , 1979, Cell.
[27] A. Levine,et al. Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells , 1982, Cell.
[28] A. Levine,et al. Association of human papillomavirus types 16 and 18 E6 proteins with p53. , 1990, Science.
[29] B. Vogelstein,et al. p53 functions as a cell cycle control protein in osteosarcomas , 1990, Molecular and cellular biology.
[30] A. Levine,et al. The p53 proto-oncogene can act as a suppressor of transformation , 1989, Cell.
[31] Yang Shi,et al. Transcriptional repression by YY1, a human GLI-Krüippel-related protein, and relief of repression by adenovirus E1A protein , 1991, Cell.
[32] F. Jensen,et al. INFECTION OF HUMAN AND SIMIAN TISSUE CULTURES WITH ROUS SARCOMA VIRUS. , 1964, Proceedings of the National Academy of Sciences of the United States of America.
[33] D. Lane,et al. Cellular proteins involved in SV40 transformation , 1983 .
[34] D. O'reilly,et al. Expression and complex formation of simian virus 40 large T antigen and mouse p53 in insect cells , 1988, Journal of virology.
[35] M. Oren,et al. Wild-type p53 can inhibit oncogene-mediated focus formation. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[36] B. Vogelstein,et al. Suppression of human colorectal carcinoma cell growth by wild-type p53. , 1990, Science.
[37] Yumay Chen,et al. Genetic mechanisms of tumor suppression by the human p53 gene , 1990, Science.
[38] A. van der Eb,et al. A new technique for the assay of infectivity of human adenovirus 5 DNA. , 1973, Virology.